Literature DB >> 1562590

Subunit structure of calgranulins A and B obtained from sputum, plasma, granulocytes and cultured epithelial cells.

D Longbottom1, J M Sallenave, V van Heyningen.   

Abstract

The calcium-binding proteins calgranulins A and B co-purified with an elastase-specific inhibitor after the affinity and cation-exchange chromatography of the perchloric acid-soluble fraction of pooled sputum collected from patients with chronic obstructive pulmonary disease (Sallenave, J.-M. and Ryle, A.P. (1991) Biol. Chem. Hoppe-Seyler 372, 13-21). The calgranulins were separated from the inhibitor by reverse-phase FPLC. Protein blot analysis of the calgranulin fraction in the absence of reducing agent revealed a band of 25 kDa corresponding to the disulphide-bonded heterodimerization of the two monomer components. Similar results were obtained from the immunoprecipitation and protein blot analysis of plasma, granulocytes and cultured epithelial cells. This implies that the calgranulins exist in the heterodimeric form in secretions in vivo. Their association with pancreatic elastase during the affinity chromatography stage of purification implicates them in the tissue destruction elicited by the inflammatory response in chronic obstructive pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562590     DOI: 10.1016/0167-4838(92)90273-g

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

2.  Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?

Authors:  Elena Bargagli; Carmela Olivieri; Marcella Cintorino; Rosa M Refini; Nicola Bianchi; Antje Prasse; Paola Rottoli
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

3.  Rapid purification and direct microassay of calbindin9kDa utilizing its solubility in perchloric acid.

Authors:  M J Hubbard
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 4.  Calprotectin in Lung Diseases.

Authors:  Ourania S Kotsiou; Dimitrios Papagiannis; Rodanthi Papadopoulou; Konstantinos I Gourgoulianis
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.